Literature DB >> 19750514

MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole.

Carine Marinach1, Alexandre Alanio, Martine Palous, Stéphanie Kwasek, Arnaud Fekkar, Jean-Yves Brossas, Sophie Brun, Georges Snounou, Christophe Hennequin, Dominique Sanglard, Annick Datry, Jean-Louis Golmard, Dominique Mazier.   

Abstract

MALDI-TOF MS can be used for the identification of microorganism species. We have extended its application to a novel assay of Candida albicans susceptibility to fluconazole, based on monitoring modifications of the proteome of yeast cells grown in the presence of varying drug concentrations. The method was accurate, and reliable, and showed full agreement with the Clinical Laboratory Standards Institute's reference method. This proof-of-concept demonstration highlights the potential for this approach to test other pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19750514     DOI: 10.1002/pmic.200900152

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  37 in total

1.  Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species.

Authors:  Elena De Carolis; Antonietta Vella; Ada R Florio; Patrizia Posteraro; David S Perlin; Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

2.  Antifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth Microdilution Testing.

Authors:  Melissa R Gitman; Lisa McTaggart; Joanna Spinato; Rahgavi Poopalarajah; Erin Lister; Shahid Husain; Julianne V Kus
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

3.  In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Authors:  Susanne Perkhofer; Cornelia Mrazek; Lukas Hartl; Cornelia Lass-Flörl
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

4.  Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours.

Authors:  Irene Burckhardt; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

Review 5.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for the Rapid Detection of Antimicrobial Resistance Mechanisms and Beyond.

Authors:  Marina Oviaño; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 6.  MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: current achievements and future perspectives.

Authors:  Georgia Vrioni; Constantinos Tsiamis; George Oikonomidis; Kalliopi Theodoridou; Violeta Kapsimali; Athanasios Tsakris
Journal:  Ann Transl Med       Date:  2018-06

Review 7.  What is new in clinical microbiology-microbial identification by MALDI-TOF mass spectrometry: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.

Authors:  Patrick R Murray
Journal:  J Mol Diagn       Date:  2012-07-11       Impact factor: 5.568

Review 8.  Next-generation antimicrobial susceptibility testing.

Authors:  Alex van Belkum; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

9.  Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

10.  Rapid species diagnosis for invasive candidiasis using mass spectrometry.

Authors:  Carine Marinach-Patrice; Arnaud Fekkar; Ralitsa Atanasova; Johanna Gomes; Laura Djamdjian; Jean-Yves Brossas; Isabelle Meyer; Pierre Buffet; Georges Snounou; Annick Datry; Christophe Hennequin; Jean-Louis Golmard; Dominique Mazier
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.